nodes	percent_of_prediction	percent_of_DWPC	metapath
Troleandomycin—CYP3A43—Dexamethasone—psoriasis	0.118	0.129	CbGbCtD
Troleandomycin—CYP2A6—Methoxsalen—psoriasis	0.0878	0.0958	CbGbCtD
Troleandomycin—CYP2C8—Tazarotene—psoriasis	0.0671	0.0733	CbGbCtD
Troleandomycin—CYP3A5—Beclomethasone—psoriasis	0.0649	0.0708	CbGbCtD
Troleandomycin—CYP2A6—Prednisolone—psoriasis	0.0427	0.0466	CbGbCtD
Troleandomycin—CYP2C8—Cholecalciferol—psoriasis	0.0287	0.0313	CbGbCtD
Troleandomycin—CYP3A5—Mycophenolate mofetil—psoriasis	0.0258	0.0282	CbGbCtD
Troleandomycin—CYP2A6—Dexamethasone—psoriasis	0.0252	0.0274	CbGbCtD
Troleandomycin—CYP2C8—Mycophenolate mofetil—psoriasis	0.0249	0.0271	CbGbCtD
Troleandomycin—CYP2C19—Cholecalciferol—psoriasis	0.024	0.0262	CbGbCtD
Troleandomycin—CYP3A4—Calcitriol—psoriasis	0.0226	0.0246	CbGbCtD
Troleandomycin—CYP3A5—Hydrocortisone—psoriasis	0.0207	0.0226	CbGbCtD
Troleandomycin—CYP2C9—Cholecalciferol—psoriasis	0.02	0.0218	CbGbCtD
Troleandomycin—CYP2C8—Hydrocortisone—psoriasis	0.0199	0.0218	CbGbCtD
Troleandomycin—CYP3A5—Cyclosporine—psoriasis	0.0196	0.0214	CbGbCtD
Troleandomycin—CYP2C8—Cyclosporine—psoriasis	0.0188	0.0206	CbGbCtD
Troleandomycin—CYP3A4—Methoxsalen—psoriasis	0.0175	0.0191	CbGbCtD
Troleandomycin—ABCB1—Mycophenolate mofetil—psoriasis	0.0168	0.0184	CbGbCtD
Troleandomycin—CYP2C19—Prednisone—psoriasis	0.0167	0.0182	CbGbCtD
Troleandomycin—CYP2C19—Cyclosporine—psoriasis	0.0158	0.0172	CbGbCtD
Troleandomycin—ABCB1—Betamethasone—psoriasis	0.0144	0.0157	CbGbCtD
Troleandomycin—ABCB1—Prednisolone—psoriasis	0.0142	0.0155	CbGbCtD
Troleandomycin—ABCB1—Hydrocortisone—psoriasis	0.0135	0.0147	CbGbCtD
Troleandomycin—ABCB1—Prednisone—psoriasis	0.0134	0.0147	CbGbCtD
Troleandomycin—CYP2C9—Cyclosporine—psoriasis	0.0131	0.0143	CbGbCtD
Troleandomycin—CYP3A5—Dexamethasone—psoriasis	0.0129	0.0141	CbGbCtD
Troleandomycin—ABCB1—Cyclosporine—psoriasis	0.0127	0.0139	CbGbCtD
Troleandomycin—CYP2C8—Dexamethasone—psoriasis	0.0124	0.0135	CbGbCtD
Troleandomycin—CYP3A4—Cholecalciferol—psoriasis	0.0116	0.0127	CbGbCtD
Troleandomycin—CYP2C19—Dexamethasone—psoriasis	0.0104	0.0114	CbGbCtD
Troleandomycin—CYP3A4—Mycophenolate mofetil—psoriasis	0.0101	0.011	CbGbCtD
Troleandomycin—CYP3A4—Triamcinolone—psoriasis	0.0101	0.011	CbGbCtD
Troleandomycin—CYP3A43—Miscellaneous substrates—CYP2S1—psoriasis	0.00983	0.118	CbGpPWpGaD
Troleandomycin—CYP2C9—Dexamethasone—psoriasis	0.00865	0.00944	CbGbCtD
Troleandomycin—CYP3A4—Betamethasone—psoriasis	0.00865	0.00944	CbGbCtD
Troleandomycin—CYP3A4—Prednisolone—psoriasis	0.00853	0.00931	CbGbCtD
Troleandomycin—ABCB1—Dexamethasone—psoriasis	0.0084	0.00916	CbGbCtD
Troleandomycin—CYP3A4—Hydrocortisone—psoriasis	0.00809	0.00883	CbGbCtD
Troleandomycin—CYP3A4—Prednisone—psoriasis	0.00806	0.00879	CbGbCtD
Troleandomycin—CYP3A4—Cyclosporine—psoriasis	0.00764	0.00833	CbGbCtD
Troleandomycin—ABCB1—Methotrexate—psoriasis	0.00675	0.00736	CbGbCtD
Troleandomycin—CYP3A43—Xenobiotics—CYP2S1—psoriasis	0.00653	0.0782	CbGpPWpGaD
Troleandomycin—CYP3A4—Dexamethasone—psoriasis	0.00503	0.00549	CbGbCtD
Troleandomycin—CYP2C18—Xenobiotics—CYP2S1—psoriasis	0.00396	0.0474	CbGpPWpGaD
Troleandomycin—CYP2A6—CYP2E1 reactions—CYP2S1—psoriasis	0.00389	0.0466	CbGpPWpGaD
Troleandomycin—CYP3A43—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.00271	0.0325	CbGpPWpGaD
Troleandomycin—CYP3A43—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.00268	0.032	CbGpPWpGaD
Troleandomycin—CYP2C8—CYP2E1 reactions—CYP2S1—psoriasis	0.00266	0.0318	CbGpPWpGaD
Troleandomycin—CYP2A6—Xenobiotics—CYP2S1—psoriasis	0.00241	0.0289	CbGpPWpGaD
Troleandomycin—CYP2C19—CYP2E1 reactions—CYP2S1—psoriasis	0.00237	0.0284	CbGpPWpGaD
Troleandomycin—CYP3A43—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.0022	0.0263	CbGpPWpGaD
Troleandomycin—CYP2C9—CYP2E1 reactions—CYP2S1—psoriasis	0.00216	0.0259	CbGpPWpGaD
Troleandomycin—CYP3A5—Xenobiotics—CYP2S1—psoriasis	0.0019	0.0228	CbGpPWpGaD
Troleandomycin—CYP2C8—Xenobiotics—CYP2S1—psoriasis	0.00165	0.0197	CbGpPWpGaD
Troleandomycin—CYP2C18—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.00164	0.0197	CbGpPWpGaD
Troleandomycin—CYP2C18—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.00162	0.0194	CbGpPWpGaD
Troleandomycin—CYP2C19—Xenobiotics—CYP2S1—psoriasis	0.00147	0.0176	CbGpPWpGaD
Troleandomycin—CYP2C9—Xenobiotics—CYP2S1—psoriasis	0.00134	0.016	CbGpPWpGaD
Troleandomycin—CYP2C18—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.00133	0.0159	CbGpPWpGaD
Troleandomycin—CYP3A43—Biological oxidations—CYP2S1—psoriasis	0.00117	0.014	CbGpPWpGaD
Troleandomycin—CYP3A43—Metapathway biotransformation—CYP2S1—psoriasis	0.00115	0.0138	CbGpPWpGaD
Troleandomycin—ABCB1—Allograft Rejection—IL22—psoriasis	0.00115	0.0138	CbGpPWpGaD
Troleandomycin—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.001	0.012	CbGpPWpGaD
Troleandomycin—CYP2A6—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000988	0.0118	CbGpPWpGaD
Troleandomycin—CYP3A4—Xenobiotics—CYP2S1—psoriasis	0.000884	0.0106	CbGpPWpGaD
Troleandomycin—CYP2A6—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000812	0.00972	CbGpPWpGaD
Troleandomycin—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.00079	0.00945	CbGpPWpGaD
Troleandomycin—CYP3A5—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000779	0.00933	CbGpPWpGaD
Troleandomycin—CYP2C18—Biological oxidations—CYP2S1—psoriasis	0.000708	0.00847	CbGpPWpGaD
Troleandomycin—CYP2C18—Metapathway biotransformation—CYP2S1—psoriasis	0.000698	0.00835	CbGpPWpGaD
Troleandomycin—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000684	0.00819	CbGpPWpGaD
Troleandomycin—CYP2C8—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000675	0.00808	CbGpPWpGaD
Troleandomycin—CYP3A5—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.00064	0.00766	CbGpPWpGaD
Troleandomycin—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NFKBIA—psoriasis	0.000627	0.0075	CbGpPWpGaD
Troleandomycin—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.00061	0.00731	CbGpPWpGaD
Troleandomycin—CYP2C18—Tryptophan metabolism—CAT—psoriasis	0.00061	0.00731	CbGpPWpGaD
Troleandomycin—CYP2C19—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000602	0.00721	CbGpPWpGaD
Troleandomycin—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000557	0.00666	CbGpPWpGaD
Troleandomycin—CYP2C8—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000554	0.00664	CbGpPWpGaD
Troleandomycin—CYP2C9—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000549	0.00658	CbGpPWpGaD
Troleandomycin—CYP2C19—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000495	0.00592	CbGpPWpGaD
Troleandomycin—ABCB1—Drug Induction of Bile Acid Pathway—VDR—psoriasis	0.000477	0.0057	CbGpPWpGaD
Troleandomycin—CYP2C9—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000451	0.0054	CbGpPWpGaD
Troleandomycin—CYP2A6—Biological oxidations—CYP2S1—psoriasis	0.000431	0.00516	CbGpPWpGaD
Troleandomycin—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—JUN—psoriasis	0.000416	0.00497	CbGpPWpGaD
Troleandomycin—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NFKB1—psoriasis	0.0004	0.00479	CbGpPWpGaD
Troleandomycin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000367	0.00439	CbGpPWpGaD
Troleandomycin—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—psoriasis	0.000363	0.00435	CbGpPWpGaD
Troleandomycin—CYP3A4—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000362	0.00434	CbGpPWpGaD
Troleandomycin—CYP3A5—Biological oxidations—CYP2S1—psoriasis	0.00034	0.00407	CbGpPWpGaD
Troleandomycin—CYP3A5—Metapathway biotransformation—CYP2S1—psoriasis	0.000335	0.00401	CbGpPWpGaD
Troleandomycin—CYP2C18—FOXA1 transcription factor network—JUN—psoriasis	0.000304	0.00363	CbGpPWpGaD
Troleandomycin—CYP3A4—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000298	0.00356	CbGpPWpGaD
Troleandomycin—CYP2C8—Biological oxidations—CYP2S1—psoriasis	0.000295	0.00353	CbGpPWpGaD
Troleandomycin—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—psoriasis	0.000294	0.00351	CbGpPWpGaD
Troleandomycin—CYP2C8—Metapathway biotransformation—CYP2S1—psoriasis	0.00029	0.00348	CbGpPWpGaD
Troleandomycin—ABCB1—HIF-1-alpha transcription factor network—CP—psoriasis	0.000283	0.00338	CbGpPWpGaD
Troleandomycin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000274	0.00328	CbGpPWpGaD
Troleandomycin—CYP2C19—Biological oxidations—CYP2S1—psoriasis	0.000263	0.00315	CbGpPWpGaD
Troleandomycin—CYP2C19—Metapathway biotransformation—CYP2S1—psoriasis	0.000259	0.0031	CbGpPWpGaD
Troleandomycin—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000256	0.00306	CbGpPWpGaD
Troleandomycin—CYP2C19—Melatonin metabolism and effects—APOE—psoriasis	0.000255	0.00305	CbGpPWpGaD
Troleandomycin—CYP2A6—NRF2 pathway—TGFA—psoriasis	0.00024	0.00287	CbGpPWpGaD
Troleandomycin—CYP2C9—Biological oxidations—CYP2S1—psoriasis	0.00024	0.00287	CbGpPWpGaD
Troleandomycin—CYP2C9—Metapathway biotransformation—CYP2S1—psoriasis	0.000236	0.00283	CbGpPWpGaD
Troleandomycin—CYP3A43—Metabolism—NDUFA5—psoriasis	0.000235	0.00281	CbGpPWpGaD
Troleandomycin—ABCB1—Allograft Rejection—HLA-C—psoriasis	0.000218	0.00261	CbGpPWpGaD
Troleandomycin—ABCB1—Allograft Rejection—IL13—psoriasis	0.000217	0.0026	CbGpPWpGaD
Troleandomycin—CYP3A43—Metabolism—CYP2S1—psoriasis	0.0002	0.00239	CbGpPWpGaD
Troleandomycin—ABCB1—Allograft Rejection—IL17A—psoriasis	0.0002	0.00239	CbGpPWpGaD
Troleandomycin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000191	0.00228	CbGpPWpGaD
Troleandomycin—ABCB1—Allograft Rejection—IL12B—psoriasis	0.000185	0.00222	CbGpPWpGaD
Troleandomycin—ABCB1—Allograft Rejection—HLA-E—psoriasis	0.000181	0.00217	CbGpPWpGaD
Troleandomycin—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000178	0.00213	CbGpPWpGaD
Troleandomycin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000169	0.00202	CbGpPWpGaD
Troleandomycin—CYP3A4—Biological oxidations—CYP2S1—psoriasis	0.000158	0.00189	CbGpPWpGaD
Troleandomycin—CYP3A4—Metapathway biotransformation—CYP2S1—psoriasis	0.000156	0.00187	CbGpPWpGaD
Troleandomycin—CYP2A6—Fluoropyrimidine Activity—TP53—psoriasis	0.000154	0.00184	CbGpPWpGaD
Troleandomycin—CYP2C19—Melatonin metabolism and effects—NFKB1—psoriasis	0.000152	0.00181	CbGpPWpGaD
Troleandomycin—ABCB1—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	0.00015	0.00179	CbGpPWpGaD
Troleandomycin—CYP2C18—Metabolism—NDUFA5—psoriasis	0.000142	0.0017	CbGpPWpGaD
Troleandomycin—CYP3A4—Tryptophan metabolism—CAT—psoriasis	0.000136	0.00163	CbGpPWpGaD
Troleandomycin—ABCB1—Allograft Rejection—IL10—psoriasis	0.000136	0.00162	CbGpPWpGaD
Troleandomycin—ABCB1—Allograft Rejection—IL4—psoriasis	0.000132	0.00158	CbGpPWpGaD
Troleandomycin—ABCB1—Allograft Rejection—HLA-B—psoriasis	0.000129	0.00154	CbGpPWpGaD
Troleandomycin—ABCB1—HIF-1-alpha transcription factor network—LEP—psoriasis	0.000129	0.00154	CbGpPWpGaD
Troleandomycin—CYP2C18—Metabolism—CYP2S1—psoriasis	0.000121	0.00145	CbGpPWpGaD
Troleandomycin—ABCB1—HIF-1-alpha transcription factor network—NOS2—psoriasis	0.00012	0.00144	CbGpPWpGaD
Troleandomycin—ABCB1—Allograft Rejection—HLA-A—psoriasis	0.00012	0.00143	CbGpPWpGaD
Troleandomycin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000118	0.00141	CbGpPWpGaD
Troleandomycin—ABCB1—Allograft Rejection—HLA-DRB1—psoriasis	0.000109	0.00131	CbGpPWpGaD
Troleandomycin—CYP3A43—Metabolism—CARM1—psoriasis	9.75e-05	0.00117	CbGpPWpGaD
Troleandomycin—CYP2A6—Metabolism—NDUFA5—psoriasis	8.67e-05	0.00104	CbGpPWpGaD
Troleandomycin—ABCB1—Allograft Rejection—IFNG—psoriasis	7.98e-05	0.000955	CbGpPWpGaD
Troleandomycin—ABCB1—HIF-1-alpha transcription factor network—JUN—psoriasis	7.96e-05	0.000953	CbGpPWpGaD
Troleandomycin—ABCB1—Allograft Rejection—CXCL8—psoriasis	7.42e-05	0.000888	CbGpPWpGaD
Troleandomycin—CYP2A6—Metabolism—CYP2S1—psoriasis	7.37e-05	0.000883	CbGpPWpGaD
Troleandomycin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—psoriasis	6.95e-05	0.000832	CbGpPWpGaD
Troleandomycin—CYP3A5—Metabolism—NDUFA5—psoriasis	6.84e-05	0.000819	CbGpPWpGaD
Troleandomycin—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	6.11e-05	0.000731	CbGpPWpGaD
Troleandomycin—ABCB1—Allograft Rejection—VEGFA—psoriasis	6.02e-05	0.000721	CbGpPWpGaD
Troleandomycin—CYP3A43—Metabolism—CAT—psoriasis	6e-05	0.000718	CbGpPWpGaD
Troleandomycin—CYP2C8—Metabolism—NDUFA5—psoriasis	5.92e-05	0.000709	CbGpPWpGaD
Troleandomycin—CYP2C18—Metabolism—CARM1—psoriasis	5.91e-05	0.000707	CbGpPWpGaD
Troleandomycin—CYP3A5—Metabolism—CYP2S1—psoriasis	5.82e-05	0.000696	CbGpPWpGaD
Troleandomycin—CYP2C8—Metabolism of lipids and lipoproteins—CARM1—psoriasis	5.52e-05	0.000661	CbGpPWpGaD
Troleandomycin—CYP2C19—Metabolism—NDUFA5—psoriasis	5.29e-05	0.000633	CbGpPWpGaD
Troleandomycin—ABCB1—Allograft Rejection—TNF—psoriasis	5.16e-05	0.000618	CbGpPWpGaD
Troleandomycin—ABCB1—Metabolism—NDUFA5—psoriasis	5.16e-05	0.000618	CbGpPWpGaD
Troleandomycin—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	5.13e-05	0.000614	CbGpPWpGaD
Troleandomycin—CYP2C8—Metabolism—CYP2S1—psoriasis	5.04e-05	0.000603	CbGpPWpGaD
Troleandomycin—CYP2C19—Metabolism of lipids and lipoproteins—CARM1—psoriasis	4.93e-05	0.00059	CbGpPWpGaD
Troleandomycin—CYP2C9—Metabolism—NDUFA5—psoriasis	4.82e-05	0.000577	CbGpPWpGaD
Troleandomycin—ABCB1—Transmembrane transport of small molecules—CP—psoriasis	4.8e-05	0.000574	CbGpPWpGaD
Troleandomycin—CYP3A43—Metabolism—APOE—psoriasis	4.66e-05	0.000558	CbGpPWpGaD
Troleandomycin—ABCB1—Transmembrane transport of small molecules—CARM1—psoriasis	4.58e-05	0.000548	CbGpPWpGaD
Troleandomycin—CYP2C19—Metabolism—CYP2S1—psoriasis	4.5e-05	0.000538	CbGpPWpGaD
Troleandomycin—CYP2C9—Metabolism of lipids and lipoproteins—CARM1—psoriasis	4.5e-05	0.000538	CbGpPWpGaD
Troleandomycin—ABCB1—Metabolism—CYP2S1—psoriasis	4.39e-05	0.000525	CbGpPWpGaD
Troleandomycin—CYP2C9—Metabolism—CYP2S1—psoriasis	4.1e-05	0.000491	CbGpPWpGaD
Troleandomycin—CYP3A43—Metabolism—PPARG—psoriasis	4.06e-05	0.000486	CbGpPWpGaD
Troleandomycin—CYP2C18—Metabolism—CAT—psoriasis	3.63e-05	0.000435	CbGpPWpGaD
Troleandomycin—CYP2A6—Metabolism—CARM1—psoriasis	3.6e-05	0.000431	CbGpPWpGaD
Troleandomycin—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	3.4e-05	0.000407	CbGpPWpGaD
Troleandomycin—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	3.27e-05	0.000392	CbGpPWpGaD
Troleandomycin—CYP3A4—Metabolism—NDUFA5—psoriasis	3.18e-05	0.000381	CbGpPWpGaD
Troleandomycin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	2.97e-05	0.000356	CbGpPWpGaD
Troleandomycin—CYP3A5—Metabolism—CARM1—psoriasis	2.84e-05	0.00034	CbGpPWpGaD
Troleandomycin—CYP2C18—Metabolism—APOE—psoriasis	2.82e-05	0.000338	CbGpPWpGaD
Troleandomycin—CYP3A4—Metabolism—CYP2S1—psoriasis	2.7e-05	0.000324	CbGpPWpGaD
Troleandomycin—CYP2C8—Metabolism of lipids and lipoproteins—APOE—psoriasis	2.64e-05	0.000316	CbGpPWpGaD
Troleandomycin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	2.55e-05	0.000305	CbGpPWpGaD
Troleandomycin—CYP2C18—Metabolism—PPARG—psoriasis	2.46e-05	0.000294	CbGpPWpGaD
Troleandomycin—CYP2C8—Metabolism—CARM1—psoriasis	2.46e-05	0.000294	CbGpPWpGaD
Troleandomycin—CYP2C19—Metabolism of lipids and lipoproteins—APOE—psoriasis	2.36e-05	0.000282	CbGpPWpGaD
Troleandomycin—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—psoriasis	2.3e-05	0.000275	CbGpPWpGaD
Troleandomycin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	2.25e-05	0.000269	CbGpPWpGaD
Troleandomycin—CYP2A6—Metabolism—CAT—psoriasis	2.21e-05	0.000265	CbGpPWpGaD
Troleandomycin—CYP2C19—Metabolism—CARM1—psoriasis	2.2e-05	0.000263	CbGpPWpGaD
Troleandomycin—CYP2C9—Metabolism of lipids and lipoproteins—APOE—psoriasis	2.15e-05	0.000257	CbGpPWpGaD
Troleandomycin—ABCB1—Metabolism—CARM1—psoriasis	2.14e-05	0.000256	CbGpPWpGaD
Troleandomycin—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—psoriasis	2.05e-05	0.000246	CbGpPWpGaD
Troleandomycin—CYP2C9—Metabolism—CARM1—psoriasis	2e-05	0.00024	CbGpPWpGaD
Troleandomycin—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.87e-05	0.000224	CbGpPWpGaD
Troleandomycin—CYP3A5—Metabolism—CAT—psoriasis	1.75e-05	0.000209	CbGpPWpGaD
Troleandomycin—CYP2A6—Metabolism—APOE—psoriasis	1.72e-05	0.000206	CbGpPWpGaD
Troleandomycin—CYP2C8—Metabolism—CAT—psoriasis	1.51e-05	0.000181	CbGpPWpGaD
Troleandomycin—CYP2A6—Metabolism—PPARG—psoriasis	1.5e-05	0.000179	CbGpPWpGaD
Troleandomycin—CYP3A5—Metabolism—APOE—psoriasis	1.36e-05	0.000162	CbGpPWpGaD
Troleandomycin—CYP2C19—Metabolism—CAT—psoriasis	1.35e-05	0.000162	CbGpPWpGaD
Troleandomycin—CYP3A4—Metabolism—CARM1—psoriasis	1.32e-05	0.000158	CbGpPWpGaD
Troleandomycin—ABCB1—Metabolism—CAT—psoriasis	1.32e-05	0.000158	CbGpPWpGaD
Troleandomycin—CYP2C9—Metabolism—CAT—psoriasis	1.23e-05	0.000147	CbGpPWpGaD
Troleandomycin—CYP3A5—Metabolism—PPARG—psoriasis	1.18e-05	0.000141	CbGpPWpGaD
Troleandomycin—CYP2C8—Metabolism—APOE—psoriasis	1.18e-05	0.000141	CbGpPWpGaD
Troleandomycin—CYP2C19—Metabolism—APOE—psoriasis	1.05e-05	0.000126	CbGpPWpGaD
Troleandomycin—ABCB1—Metabolism—APOE—psoriasis	1.02e-05	0.000123	CbGpPWpGaD
Troleandomycin—CYP2C8—Metabolism—PPARG—psoriasis	1.02e-05	0.000123	CbGpPWpGaD
Troleandomycin—CYP2C9—Metabolism—APOE—psoriasis	9.57e-06	0.000115	CbGpPWpGaD
Troleandomycin—CYP2C19—Metabolism—PPARG—psoriasis	9.14e-06	0.000109	CbGpPWpGaD
Troleandomycin—ABCB1—Metabolism—PPARG—psoriasis	8.92e-06	0.000107	CbGpPWpGaD
Troleandomycin—CYP2C9—Metabolism—PPARG—psoriasis	8.33e-06	9.97e-05	CbGpPWpGaD
Troleandomycin—CYP3A4—Metabolism—CAT—psoriasis	8.12e-06	9.72e-05	CbGpPWpGaD
Troleandomycin—CYP3A4—Metabolism—APOE—psoriasis	6.31e-06	7.55e-05	CbGpPWpGaD
Troleandomycin—CYP3A4—Metabolism—PPARG—psoriasis	5.5e-06	6.58e-05	CbGpPWpGaD
